Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Seminars in Cancer Biology
Dingxiao ZhangKiera Rycaj

Abstract

It is becoming increasingly clear that virtually all types of human cancers harbor a small population of stem-like cancer cells (i.e., cancer stem cells, CSCs). These CSCs preexist in primary tumors, can self-renew and are more tolerant of standard treatments, such as antimitotic and molecularly targeted agents, most of which preferentially eliminate differentiated and proliferating cancer cells. CSCs are therefore postulated as the root of therapy resistance, relapse and metastasis. Aside from surgery, radiation, and chemotherapy, immunotherapy is now established as the fourth pillar in the therapeutic armamentarium for patients with cancer, especially late-stage and advanced cancers. A better understanding of CSC immunological properties should lead to development of novel immunologic approaches targeting CSCs, which, in turn, may help prevent tumor recurrence and eliminate residual diseases. Here, with a focus on CSCs in solid tumors, we review CSC regulation programs and recent transcriptomics-based immunological profiling data specific to CSCs. By highlighting CSC antigens that could potentially be immunogenic, we further discuss how CSCs can be targeted immunologically.

References

Jul 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Micha DrukkerNissim Benvenisty
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Jun 4, 2008·Cancer Research·Maria Giovanna FrancipaneGiorgio Stassi
Jun 19, 2008·Stem Cell Reviews·C R A RegenbrechtJ Adjaye
Mar 7, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roberta CastriconiCristina Bottino
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer S KoJames H Finke
May 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matilde TodaroGiorgio Stassi
Jun 6, 2009·International Immunology·Gabriella PietraMaria Cristina Mingari
Jul 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Douglas G McNeelGeorge Wilding
Sep 8, 2009·Expert Review of Molecular Diagnostics·Oswaldo Keith Okamoto
Sep 10, 2009·Cell·Mark ShackletonSean J Morrison
Jan 7, 2010·The Journal of Clinical Investigation·Christophe GinestierMax S Wicha
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nabil AhmedStephen Gottschalk
Jan 14, 2010·Cancer Research·Tobias SchattonMarkus H Frank
Jan 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tiziano Di TomasoCristina Maccalli
Feb 25, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Richard A MorganSteven A Rosenberg
Jun 10, 2010·BMC Biology·James Chappell, Stephen Dalton
Sep 15, 2010·Nature Reviews. Clinical Oncology·Rakesh K Jain, Triantafyllos Stylianopoulos
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 26, 2011·The American Journal of Pathology·Satoko InodaNoriyuki Sato
May 31, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marcello Maugeri-SaccàRuggero De Maria
Jun 21, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hasan KorkayaMax S Wicha
Aug 23, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carmen VisusXinhui Wang
Sep 6, 2011·Annual Review of Medicine·Andrew Z WangOmid C Farokhzad
Oct 4, 2011·The Journal of Clinical Investigation·Hasan KorkayaMax S Wicha

❮ Previous
Next ❯

Citations

Nov 13, 2018·Journal of Cellular Physiology·Masoud NajafiKeywan Mortezaee
Nov 24, 2019·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Shilpa RavindranCristina Maccalli
Dec 4, 2019·Nature Reviews. Clinical Oncology·Joseph A ClaraNaoko Takebe
Aug 19, 2020·Cancer Immunology, Immunotherapy : CII·A RaniszewskaJ Domagała-Kulawik
Aug 28, 2020·Frontiers in Immunology·Lia WalcherUta Kossatz-Boehlert
Jul 3, 2019·Frontiers in Oncology·Ziyang FengMinghua Wu
Jul 8, 2020·The Journal of Clinical Investigation·Jessica LovnickiXuesen Dong
Nov 13, 2018·Frontiers in Oncology·Katia C GenadryCorinne M Linardic
Mar 8, 2019·Cancers·Narayanasamy Badrinath, So Young Yoo
Nov 21, 2020·Immunology and Cell Biology·Laverne D RobilliardE Scott Graham
Jul 3, 2019·Seminars in Cancer Biology·Monica MarzagalliPatrizia Limonta
Jan 12, 2021·Molecular Carcinogenesis·Naing L ShanNanjoo Suh
Sep 8, 2019·Cancer Letters·Tsing TsaoYong Li
Sep 5, 2018·EBioMedicine·Dingxiao Zhang, Dean G Tang
Oct 26, 2018·Trends in Cancer·Dingxiao ZhangDean G Tang
Nov 12, 2018·Biochemical Pharmacology·François M ValletteDominique Heymann
Jul 28, 2020·Cancer Letters·Stéphane TerrySalem Chouaib
Apr 20, 2021·Frontiers in Immunology·Yunkai Yang, Yan Wang
May 13, 2021·Seminars in Cancer Biology·Sukanya BasuDean G Tang
Jun 25, 2021·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Ethan J Kilmister, Swee T Tan
Jul 3, 2021·Cancers·Agata RaniszewskaJoanna Domagała-Kulawik
Aug 4, 2021·International Journal of Oral Science·Areeg ElmusratiCun-Yu Wang
Aug 13, 2021·Frontiers in Oncology·Giuliana CataraDaniela Spano
Oct 31, 2021·Journal of Hematology & Oncology·Jiangling XiongDingxiao Zhang
May 8, 2021·Stem Cells·Michael RückertUdo S Gaipl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.